CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- 4 Open-market buy Director bought 1,714,285 shares at $7.00 ($11,999,995)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 285,714 shares at $7.00 ($1,999,998)
- 4 Open-market buy SVP, Finance, Chief Acct Offcr bought 5,714 shares at $7.00 ($39,998)
- 4 Open-market buy Chief Financial Officer bought 14,285 shares at $7.00 ($99,995)
- 4 Open-market sale Chief Development Officer sold 2,212 shares at an average $19.49 ($43,116)
- 4 Open-market sale Chief Development Officer sold 19,711 shares at an average $18.26 ($359,973)
- 4 Open-market sale Chief Development Officer sold 494 shares at $16.47 ($8,136)
- 4 Open-market sale Chief Development Officer sold 3,289 shares at an average $15.85 ($52,128)
- 4 Exercise or conversion President and CEO acquired 65,153 shares (option exercise)
- 4 Open-market sale Chief Development Officer sold 494 shares at $16.54 ($8,171)
- 4 Open-market sale Chief Development Officer sold 8,590 shares at an average $19.41 ($166,735)
- 4 Open-market sale Chief Development Officer sold 988 shares at $21.64 ($21,380)
- 4 Open-market sale President and CEO sold 32,000 shares at an average $20.90 ($668,773)
- 4 Open-market sale Chief Development Officer sold 16,840 shares at an average $20.72 ($348,944)
- 4 Open-market sale President and CEO sold 22,363 shares at an average $21.16 ($473,236)
- 4/A Insider Changes in Ownership
- 4 Open-market sale President and CEO sold 29,022 shares at an average $20.43 ($592,812)
- 4 Open-market sale President and CEO sold 21,891 shares at an average $20.37 ($445,879)
- 4 Open-market sale Chief Development Officer sold 988 shares at $18.63 ($18,406)
Page 8 of 12 · 230 filings